Highlights
- First-in-human study of a regenerative material for dialysis access demonstrates initial safety and mechanical durability.
- Interventional nephrology’s place in kidney care explored following Twitter controversy.
- PROFILE: Neghae Mawla (Dallas, USA)
- American Society of Diagnostic and Interventional Nephrology (ASDIN) Annual Meeting covered in depth.
- PAVE-2 trial evidence assessed by co-authors on the study
- Transplantation issues explored, including sex-based outcome differences and the need for live-donor transplants
